Surender Singh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1399 Washington St, Hanover, MA 02334 Phone: 781-829-1000 Fax: 781-829-9117 |
News Archive
States struggle with funding health care for inmates, Medicaid cuts and funding health insurance for low-income residents in Minnestoa.
Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation, today announced initial results from a Phase I multicenter safety study of PDA-001 in treatment-resistant Crohn's Disease. PDA-001 is an immunomodulatory therapy consisting of human placenta-derived cells obtained from CCT's proprietary processes.
A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms of MS and compared to treatments for other chronic diseases.
A biochemical pathway that helps keep cells alive when oxygen is low also plays a role in longevity and resistance against some diseases of old age, according to a report to be published April 16 in the journal Science.
Today's early morning highlights from the major news organizations include news on congressional package to payroll taxes and stop a Medicare payment cut and analysis of President Barack Obama's budget.
› Verified 3 days ago